and molecular levels. Med Clin North Am. 2009; 93:583–604.
28 28. Sandow SL, Senadheera S, Grayson TH, et al. Calcium and endothelium‐mediated vasodilator signaling. Adv Exp Med Biol. 2012; 740:811–831.
29 29. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immutable cardiovascular risk factor? Hypertension. 2005; 46:454–462.
30 30. Thorin E, Thorin‐Trescases N. Vascular endothelial ageing, heartbeat after heartbeat. Cardiovasc Res. 2009; 84:24–32.
31 31. Lim MA, Townsend RR. Arterial compliance in the elderly: its effect on blood pressure measurement and cardiovascular outcomes. Clin Geriatr Med. 2009; 25:191–205.
32 32. Izzo JL Jr. Arterial stiffness and the systolic hypertension syndrome. Curr Opin Cardiol. 2004; 19:341–352.
33 33. Morley JE, McKee A. Endocrinology of aging. In: Fillit HM, Rockwood K, Young J, eds. Brocklehurst’s Textbook of Geriatric Medicine and Gerontology. 8th ed. Elsevier; 2017:139.
34 34. Rozing MP, Houwing‐Duistermaat JJ, Slagboom PE, et al. Familial longevity is associated with decreased thyroid function. J Clin Endocrinol Metab. 2010; 95:4979–4984.
35 35. Aztmon G, Barzilai N, Surks MI, et al. Genetic predisposition to elevated serum thyrotropin is associated with exceptional longevity. J Clin Endocrinol Metab. 2009; 94:4768–4775.
36 36. Veldhuis JD, Bowers CY. Human GH pulsatility: An ensemble property regulated by age and gender. J Endocrinol Invest. 2003; 26:799–813.
37 37. Maison P, Balkau B, Simon D, et al. Growth hormone as a risk for premature mortality in healthy subjects: data from the Paris prospective study. BMJ. 1998; 316:1132–1133.
38 38. Haren MT, Malmstrom TK, Banks WA, et al. Lower serum DHEAS levels are associated with a higher degree of physical disability and depressive symptoms in middle‐aged to older African American women. Maturitas. 2007; 57:347–360.
39 39. Prentice RL, Anderson GL. The Women’s Health Initiative: lessons learned. Annu Rev Public Health. 2008; 29:131–150.
40 40. Yassin DJ, El Douaihy Y, Yassin AA, et al. Lower urinary tract symptoms improve with testosterone replacement therapy in men with late‐onset hypogonadism: 5–year prospective, observational and longitudinal registry study. World J Urol. 2014; 32:1049–1054.
41 41. Matsumoto AM. Testosterone administration in older men. Endocrinol Metab Clin North Am. 2013; 42:271–286.
42 42. Varadhan R, Walston J, Cappola AR, et al. Higher levels and blunted diurnal variation of cortisol in frail older women. J Gerontol. A Biol Sci Med Sci. 2008; 63:190–195.
43 43. Weidmann P, De Myttenaere‐Burztein S, Maxwell MH, et al. Effect of aging on plasma renin and aldosterone in normal man. Kidney Int. 1975; 8:325–333.
44 44. Findley T. Role of the neurohypophysis in the pathogenesis of hypertension and some allied disorders associated with aging. Am J Med. 1949; 7:70–84.
45 45. Dharmarajan TS, Pitchumoni CS, Kokkat AJ. The aging gut. Pract Gastroenterol. 2001; 25:15–27.
46 46. Morley JE. The aging gut: physiology. Clin Geriatr Med. 2007; 23:757–767.
47 47. Dharmarajan TS, Ugalino JT, Kathpalia R. Anorexia in older adults: consequences of aging or disease? Pract Gastroenterol. 1999; 23:82–92.
48 48. Brandt LJ. In Capell MS, Upper gastrointestinal diseases and the elderly: an interview. Intern Med World Rep. 1995; 10(Suppl):1–2.
49 49. Kao CH, Lai TL, Wang SJ, et al. Influence of age on gastric emptying in healthy Chinese. Clin Nucl Med. 1994; 19:401–404.
50 50. Holt PR. Intestinal malabsorption in the elderly. Dig Dis. 2007; 25:144–150.
51 51. Elmadfa I, Meyer AL. Body composition, changing physiological functions and nutrient requirements of the elderly. Ann Nutr Metab. 2008; 52(Suppl 1):2–5.
52 52. Eisborg L. Reversible malabsorption of folic acid in the elderly with nutritional folate deficiency. Acta Haematol. 1976; 55:140–147.
53 53. Madsen JL, Graff J. Effects of ageing on gastrointestinal motor function. Age Ageing. 2004; 33:154–159.
54 54. Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017; 474(11):1823–1836.
55 55. Popper H. Aging and the liver. In: Popper H and Schaffner F, eds. Progress in Liver Disease. 8th ed. Grune and Stratton; 1986:659–683.
56 56. Affronti J. Biliary disease in the elderly patient. Clin Geriatr Med. 1999; 15:571–578.
57 57. Gloor B, Ahmed Z, Uhl W. Pancreatic disease in the elderly. Best Pract Res Clin Gastroenterol. 2002; 16:159–170.
58 58. Harewood GC, Lawlor GO, Larson MV. Incident rates of colonic neoplasia in older patients: when should we stop screening? J Gastroenterol Hepatol. 2006; 21:1021–1025.
59 59. Zhou XJ, Rakheja D, Yu X, et al. The aging kidney. Kidney Int. 2008; 74:710–720.
60 60. Rowe JW, Andres R, Tobin JD, et al. The effect of age on creatinine clearance in men: a cross‐sectional and longitudinal study. J Gerontol. 1976; 31:155–163.
61 61. Giannelli SV, Patel KV, Windham BG, et al. Magnitude of underascertainment of impaired kidney function in older adults with normal serum creatinine. J Am Geriatr Soc. 2007; 55:816–823.
62 62. Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis. 2001; 37:79–83.
63 63. Hollenberg NK, Adams DF, Solomon HS, et al. Senescence and the renal vasculature in normal man. Circ Res 1974; 34:309–316.
64 64. Kuchel GA. Aging and homeostatic regulation. In: Halter JB, Hazzard WR, Ouslander JG et al, eds. Hazzard’s Principles of Geriatric Medicine And Gerontology. 3rd ed. McGraw Hill; 2008.
65 65. Rule AD, Jacobson DJ, McGree ME, et al. Longitudinal changes in post‐void residual and voided volume among community dwelling men. J Urol. 2005; 174:1317–1321.
66 66. Ustinova EE, Fraser MO, Pezzone MA Cross‐talk and sensitization of bladder afferent nerves. Neurourol Urodyn. 2010; 29:77–81.
67 67. Kuchel GA, Moscufo N, Guttmann CR, et al. Localization of brain white matter hyperintensities and urinary incontinence in community‐dwelling older adults. J Gerontol. A Biol Sci Med Sci. 2009; 64:902–909.
68 68. Smith PP, Chalmers DJ, Feinn RS. Does defective volume sensation contribute to detrusor underactivity? Neurourol Urodyn. 2015; 34:752–756. doi: 10.1002/nau.22653.
69 69. Gunes S, et al. Effects of aging on the male reproductive system. J Assist Reprod Genet. 2016; 33(4):441–54.
70 70. Shirasuna K, Iwata H. Effect of aging on the female reproductive function. Contracept Reprod Med. 2017; 2:23.
71 71. Ventura MT, et al. Immunosenescence in aging: between immune cells depletion and cytokines up‐regulation. Clin Mol Allergy. 2017; 15:21.
72 72. Xia S, et al. An update on inflamm‐aging: mechanisms, prevention, and treatment. J Immunol Res. 2016:8426874.
73 73. Kevorkian RT, Morley JE. The physiology of ageing. In: Sinclair AJ, Morley JE, Vellas B, eds. Pathy’s Principles and Practice of Geriatric Medicine. 5th ed. John Wiley and Sons, Ltd. Wiley‐Blackwell; 2012:38.
74 74. Pouilles JM, Tremollieres F, Ribot C. Effect of menopause on femoral and vertebral bone loss. J Bone Miner Res. 1995; 10:1531–1536.
75 75. Todd RC, Freeman MA, Pirie CJ. Isolated trabecular fatigue fractures in the femoral head. J Bone Joint Surg Br. 1972; 54:723–728.
76 76. Oxlund H, Mosekilde L, Ortoft G. Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis. Bone. 1996; 19:479–484.
77 77. Nakashima T, et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011; 17:1231–1234.
78 78. Yeung RS. The osteoprotegerin/osteoprotegerin